Financial Toxicity Encountered in Therapeutic Radiopharmaceutical Clinical Development for Ovarian Cancer

Financial toxicity or the debt a cancer survivor incurs from the costs of their medical cancer care is an understudied aspect in the clinical development of experimental therapeutic agents. The United States National Cancer Institute (NCI) Cancer Therapy Evaluation Program studies experimental thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunos, Charles A., Abdallah, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464475/
https://www.ncbi.nlm.nih.gov/pubmed/32764223
http://dx.doi.org/10.3390/ph13080181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464475/
https://www.ncbi.nlm.nih.gov/pubmed/32764223
http://dx.doi.org/10.3390/ph13080181

Ejemplares similares